全文获取类型
收费全文 | 1124篇 |
免费 | 98篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 85篇 |
妇产科学 | 10篇 |
基础医学 | 110篇 |
口腔科学 | 29篇 |
临床医学 | 178篇 |
内科学 | 248篇 |
皮肤病学 | 12篇 |
神经病学 | 35篇 |
特种医学 | 249篇 |
外科学 | 68篇 |
综合类 | 23篇 |
预防医学 | 72篇 |
眼科学 | 8篇 |
药学 | 49篇 |
中国医学 | 6篇 |
肿瘤学 | 42篇 |
出版年
2023年 | 9篇 |
2021年 | 11篇 |
2020年 | 7篇 |
2019年 | 8篇 |
2018年 | 24篇 |
2017年 | 13篇 |
2016年 | 23篇 |
2015年 | 23篇 |
2014年 | 28篇 |
2013年 | 28篇 |
2012年 | 21篇 |
2011年 | 24篇 |
2010年 | 35篇 |
2009年 | 54篇 |
2008年 | 28篇 |
2007年 | 16篇 |
2006年 | 17篇 |
2005年 | 10篇 |
2004年 | 12篇 |
2003年 | 24篇 |
2002年 | 22篇 |
2001年 | 17篇 |
2000年 | 20篇 |
1999年 | 18篇 |
1998年 | 51篇 |
1997年 | 56篇 |
1996年 | 69篇 |
1995年 | 53篇 |
1994年 | 45篇 |
1993年 | 48篇 |
1992年 | 19篇 |
1991年 | 16篇 |
1990年 | 25篇 |
1989年 | 43篇 |
1988年 | 35篇 |
1987年 | 41篇 |
1986年 | 37篇 |
1985年 | 36篇 |
1984年 | 18篇 |
1983年 | 16篇 |
1982年 | 25篇 |
1981年 | 15篇 |
1980年 | 9篇 |
1979年 | 5篇 |
1978年 | 6篇 |
1977年 | 16篇 |
1976年 | 13篇 |
1975年 | 15篇 |
1972年 | 3篇 |
1971年 | 6篇 |
排序方式: 共有1229条查询结果,搜索用时 31 毫秒
1.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
2.
David Langton Diana Way Lisbeth Trigg Duncan Blake Barry McGrath 《Clinical and experimental pharmacology & physiology》1990,17(3):219-223
1. The effects of graded treadmill exercise on renal blood flow (RBF) were examined in seven rabbits, in which congestive heart failure (CHF) was produced by the administration of doxorubicin, 1 mg/kg, twice weekly for 8 weeks, and in seven controls. A third group of five rabbits underwent doxorubicin treatment with the addition of surgical section of the left renal sympathetic nerve. 2. During submaximal exercise, there was a small reduction in RBF in controls, which was greatly exaggerated in CHF. 3. In both control and heart failure rabbits, there was a precipitous fall in RBF as exercise fatigue developed. 4. Renal sympathectomy ablated these changes in RBF during exercise. 5. It is concluded that in heart failure there is an exaggerated, sympathetically mediated, diversion of blood flow away from the kidney. The onset of exercise fatigue in both normal and heart failure rabbits is accompanied by a marked intensification of this process. 相似文献
3.
4.
5.
6.
7.
8.
Multiple routes of vascular access are required in children undergoing bone marrow transplantation to facilitate total parenteral nutrition (TPN); blood withdrawal; and administration of blood products, antibiotics, fluids, and immunosuppressive drugs. Placement of multiple catheters frequently requires multiple venotomies in separate vessels. We have found that both a Broviac catheter and pediatric dual-lumen Raaf catheter can be placed through separate venotomies in the external jugular vein, which provides sufficient routes of vascular access without complications. This technique places only one vessel at risk while minimizing the chance for infection by utilizing two exit sites. We consider this to be the procedure of choice in young patients requiring multiple routes of vascular access. 相似文献
9.
10.